Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter‐Defibrillators in the Cardiovascular Research Network

BACKGROUND: Primary prevention implantable cardioverter‐defibrillators (ICDs) reduce mortality in selected patients with left ventricular systolic dysfunction by delivering therapies (antitachycardia pacing or shocks) to terminate potentially lethal arrhythmias; inappropriate therapies also occur. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenlee, Robert T., Go, Alan S., Peterson, Pamela N., Cassidy‐Bushrow, Andrea E., Gaber, Charles, Garcia‐Montilla, Romel, Glenn, Karen A., Gupta, Nigel, Gurwitz, Jerry H., Hammill, Stephen C., Hayes, John J., Kadish, Alan, Magid, David J., McManus, David D., Multerer, Deborah, Powers, J. David, Reifler, Liza M., Reynolds, Kristi, Schuger, Claudio, Sharma, Param P., Smith, David H., Suits, Mary, Sung, Sue Hee, Varosy, Paul D., Vidaillet, Humberto J., Masoudi, Frederick A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907599/
https://www.ncbi.nlm.nih.gov/pubmed/29581222
http://dx.doi.org/10.1161/JAHA.117.008292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907599/
https://www.ncbi.nlm.nih.gov/pubmed/29581222
http://dx.doi.org/10.1161/JAHA.117.008292

Ejemplares similares